Excision BioTherapeutics Inc
Biotechnology company · San Francisco, California, United States
Excision BioTherapeutics Inc is a biotechnology company headquartered in San Francisco, California, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $217,484 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2021.
Excision BioTherapeutics at a glance
What does Excision BioTherapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $217,484 in total (2019). NIH funding came from the National Institute of General Medical Sciences.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $10.5 million sold (2021).
Frequently asked questions about Excision BioTherapeutics
Where is Excision BioTherapeutics headquartered?
Excision BioTherapeutics Inc is headquartered in San Francisco, California, United States.
What does Excision BioTherapeutics do?
Excision BioTherapeutics Inc is a biotechnology company.
Similar companies
- Cytovale Inc.San Francisco, California, United States
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.